Active substances
Bisoprolol + Perindopril
- SFDA 2
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| COSYREL 5MG/10MG F.C.TABLET | 10,5 mg,mg | Film-coated tablet · Oral use | 30 Bottle | SAR 54.40 | NCE · Prescription | LES LABORATOIRES SERVIER | Valid |
| COSYREL 5MG/5MG F.C.TABLET | 5,5 mg,mg | Film-coated tablet · Oral use | 30 Bottle | SAR 41.15 | NCE · Prescription | LES LABORATOIRES SERVIER | Valid |
Indications — CHI Daman Drug Formulary
CORONARY ARTERY DISEASE; HYPERTENSION
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.